Abstract
In highly developed countries like USA, approximately one out of 6 in the male population will expect to have prostate cancer in their life time. Chemoprevention is presumably one of most effective means to combat many types of cancer including prostate cancer (PCa). Because clinically significant PCa usually requires more than a decade to develop, therefore, it would be an ideal target for chemoprevention. This review will focus on recent findings of the most studied, naturally occurring, synthetic or semi-synthetic chemicals for potential use in preventing PCa. Newly discovered chemicals which show potential in preventative or therapeutic effects will be included. Molecular mechanisms and gene/pathway targets by which the above agents act on target cells will be briefly discussed. The recent findings on the chemicals possessing anti-androgen receptor, anti-DNA methyltransferase, or anti-histone deacetyltransferase activity will also be presented. It will further present some important issues regarding how the interactions of chemopreventing agents with genetic polymorphisms or epigenetic factors might affect anti-cancer effects of the agents. Related large trials, if appropriate, will also be discussed.
Keywords: Prostate cancer, dietary chemicals, chemoprevention, epigenetic, genetic polymorphism
Current Cancer Drug Targets
Title: Recent Approaches in Chemoprevention of Prostate Cancer
Volume: 7 Issue: 7
Author(s): Charles Y.F. Young
Affiliation:
Keywords: Prostate cancer, dietary chemicals, chemoprevention, epigenetic, genetic polymorphism
Abstract: In highly developed countries like USA, approximately one out of 6 in the male population will expect to have prostate cancer in their life time. Chemoprevention is presumably one of most effective means to combat many types of cancer including prostate cancer (PCa). Because clinically significant PCa usually requires more than a decade to develop, therefore, it would be an ideal target for chemoprevention. This review will focus on recent findings of the most studied, naturally occurring, synthetic or semi-synthetic chemicals for potential use in preventing PCa. Newly discovered chemicals which show potential in preventative or therapeutic effects will be included. Molecular mechanisms and gene/pathway targets by which the above agents act on target cells will be briefly discussed. The recent findings on the chemicals possessing anti-androgen receptor, anti-DNA methyltransferase, or anti-histone deacetyltransferase activity will also be presented. It will further present some important issues regarding how the interactions of chemopreventing agents with genetic polymorphisms or epigenetic factors might affect anti-cancer effects of the agents. Related large trials, if appropriate, will also be discussed.
Export Options
About this article
Cite this article as:
Young Y.F. Charles, Recent Approaches in Chemoprevention of Prostate Cancer, Current Cancer Drug Targets 2007; 7 (7) . https://dx.doi.org/10.2174/156800907782418284
DOI https://dx.doi.org/10.2174/156800907782418284 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
Call for Papers in Thematic Issues
Advances in Cancer Biomarkers and Potential Drug Targets: From Diagnosis to Therapy
Cancer biomarkers play a crucial role in the diagnosis, prognosis, and treatment of cancer. They provide valuable information for cancer detection, risk assessment, treatment selection, and monitoring response to therapy. With advancements in molecular biology and high-throughput technologies, there has been an increasing interest in identifying and characterizing cancer biomarkers ...read more
Novel Therapeutic Approaches to Target Drug Resistant Tumors
With the development of disciplines such as chemical biology and molecular biology, the genes or proteins closely related to tumor occurrence and development have gradually become clear. Targeted therapies targeting these genes or proteins provide more effective methods for tumor treatment. Tumor targeted drugs generally only act on specific targets ...read more
ROLE OF IMMUNE AND GENOTOXIC RESPONSE BIOMARKERS IN TUMOR MICROENVIRONMENT IN CANCER DIAGNOSIS AND TREATMENT
Biological biomarkers have been used in medical research as an indicator of a normal or abnormal process inside the body, or of a disease. Nowadays, various researchers are in process to explore and investigate the biological markers for the early assessment of cancer. DNA Damage response (DDR) pathways and immune ...read more
Targeting the battlefield between host and tumor: basic research and clinical practice on reshaping tumor immune microenvironment
Immune system protects host against malignant tumors through effector cells and molecules. Cancer development and its response to therapy are regulated by inflammation, which either promotes or suppresses cancer progression. Chronic inflammation facilitates cancer progression and treatment resistance, whereas induction of acute inflammatory reactions often lead to anti-cancer immune responses. ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Olive Oil and Cancer Risk: an Update of Epidemiological Findings through 2010
Current Pharmaceutical Design Radioprotective Effect of Gliclazide as an Anti-Hyperglycemic Agent Against Genotoxicity Induced by Ionizing Radiation on Human Lymphocytes
Cardiovascular & Hematological Agents in Medicinal Chemistry Gold and Silver Nanoparticles for Applications in Theranostics
Current Topics in Medicinal Chemistry Metabolic Effects of Resveratrol in Mammals - a Link Between Improved Insulin Action and Aging
Current Aging Science Phosphoinositide 3-Kinases as Targets for Therapeutic Intervention
Current Pharmaceutical Design Ureas: Applications in Drug Design
Current Medicinal Chemistry Cyclodextrins for Non-Viral Gene and siRNA Delivery
Pharmaceutical Nanotechnology Thyroid: Iodine Beyond the Thyronines
Current Chemical Biology Molecular Modeling Based Synthesis and Evaluation of <i>In vitro</i> Anticancer Activity of Indolyl Chalcones
Current Topics in Medicinal Chemistry Bee Venom: Its Potential Use in Alternative Medicine
Anti-Infective Agents Graphical Abstracts:
Current Radiopharmaceuticals Immunomics in Skin Cancer - Improvement in Diagnosis, Prognosis and Therapy Monitoring
Current Proteomics Current State of ERG as Biomarker in Prostatic Adenocarcinoma
Current Cancer Drug Targets Recent Patents in Glycan-Based Cancer Biomarkers and Discovery Technologies
Recent Patents on Biomarkers Intra-uterine Growth Retardation as a Risk Factor of Postnatal Metabolic Disorders
Current Pharmaceutical Biotechnology Glycosidated Phospholipids – a Promising Group of Anti-Tumour Lipids
Anti-Cancer Agents in Medicinal Chemistry Methylenedioxy- and Ethylenedioxy-Fused Indolocarbazoles: Potent Human Topoisomerase I Inhibitors and Antitumor Agents
Anti-Cancer Agents in Medicinal Chemistry 2D-Gel Electrophoresis Analysis of Proteomic Changes in Three Human Cell Lines; HEK 293, HepG2 and 1321N1 Cells in Response to Cadmium
Current Proteomics Signaling Through Rho GTPase Pathway as Viable Drug Target
Current Medicinal Chemistry Curcumin: Powerful Immunomodulator from Turmeric
Current Immunology Reviews (Discontinued)